A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)-Reference-Cited by-同舟云学术

A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Published:2017-11-16 Issue:4 Volume:121 Page:647-658
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Roehrborn Claus G.¹,Manyak Michael J.²,Palacios-Moreno Juan Manuel³^ORCID,Wilson Timothy H.⁴,Roos Erik P.M.⁵,Santos Javier Cambronero⁶,Karanastasis Dimitrios⁷,Plastino Janet⁸,Giuliano François⁹,Rosen Raymond C.¹⁰

Affiliation:

1. Department of Urology; University of Texas (UT) Southwestern Medical Center; Dallas TX USA

2. GlaxoSmithKline (GSK); Washington DC USA

3. GSK; Madrid Spain

4. PAREXEL International; Durham NC USA

5. Antonius Ziekenhuis Sneek; Sneek The Netherlands

6. Hospital Universitario Infanta Leonor; Madrid Spain

7. Urologic Clinic; General Hospital of Athens ‘Elpis’; Athens Greece

8. GSK; Collegeville PA USA

9. Neuro-Urology R. Poincare Hospital AP-HP; Garches; UMR1179 Inserm-UVSQ-Paris Saclay University; Paris, France France

10. New England Research Institutes; Watertown MA USA

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14057/fullpdf

Reference35 articles.

1. Benign prostatic hyperplasia: risk factors and management;Nash;GM,2010

2. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Rosen;BJU Int,2009

3. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study;Roehrborn;Eur Urol,2010

4. Gravas S Bach T Bachmann A et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) 2016 https://uroweb.org/wp-content/uploads/Non-Neurogenic-Male-LUTS_2705.pdf

5. Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey;Emberton;Int J Clin Pract,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men;American Journal of Men's Health;2023-11

2. The post-finasteride syndrome: possible etiological mechanisms and symptoms;International Journal of Impotence Research;2023-09-11

3. Effects of dutasteride and tamsulosin on penile morphology in a rodent model;International braz j urol;2023-06

4. Evaluation of sexual function after dutasteride treatment in patients with once-negative prostate biopsy and benign prostate hyperplasia;Urologia Journal;2023-03-29

5. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression;European Urology Focus;2023-01